Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours. - Wikidata - awgldk - TriplyDB

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

http://www.wikidata.org/entity/Q35070122

about

Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images Imaging of oligodendroglioma Magnetic resonance perfusion imaging in neuro-oncology.Functional imaging in adult and paediatric brain tumours.Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy.Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.Genetics and imaging of oligodendroglial tumors.Advanced MRI in the management of adult gliomas.The role of advanced MR imaging in understanding brain tumour pathology.Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging.IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI Comparative analysis of arterial spin labeling and dynamic susceptibility contrast perfusion imaging for quantitative perfusion measurements of brain tumors Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.Biology, genetics and imaging of glial cell tumours Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas.Perfusion and diffusion MRI combined with ¹¹C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas.'Recurrent' glioblastoma multiforme, when should we reoperate?Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging.Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms.Silent Sentence Completion Shows Superiority Localizing Wernicke's Area and Activation Patterns of Distinct Language Paradigms Correlate with Genomics: Prospective Study.Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate.Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.11C-methionine uptake correlates with combined 1p and 19q loss of heterozygosity in oligodendroglial tumors.MR textural analysis on T2 FLAIR images for the prediction of true oligodendroglioma by the 2016 WHO genetic classification.3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas.Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors.Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?Enhancing fraction in glioma and its relationship to the tumoral vascular microenvironment: A dynamic contrast-enhanced MR imaging study.Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice.Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours.Conventional and advanced magnetic resonance imaging in patients with high grade glioma.Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.

P2860

Q26743358-8F29E52C-01F8-42E1-8BC3-3CEED9D58814 Q26768596-79C3BF21-4964-4F5C-8DDC-CEE53CBB2291 Q30479156-4D27BB5E-6CA3-4F4F-B48F-112DD9C09139 Q30577397-F9E53EF9-7352-499E-892F-C4508BE86702 Q30872679-58239F8C-5947-41D5-83D0-D3102B3A1D63 Q30984368-8882959C-6A95-4EE4-B71C-1695F9F2EEB4 Q31007575-8C9EC6A6-61BE-46D8-896B-7868AFE268D1 Q31139548-D145B711-5839-4123-8782-0EC1E0FA5389 Q33309683-0E554312-BFBB-426A-9C28-FFF077E8C336 Q33718802-742875A0-EA54-4ED7-8121-244A3716889C Q33733375-25B38B50-7F13-4FCF-B8D7-6900F2A5BE5B Q33898480-4C11B74A-A97C-49BB-895F-2024A00C8A4B Q33904348-01A79EE9-EB02-460F-BA77-02EC80247F2D Q34203930-5294FDD4-BF68-497C-93A6-3373AE464C6A Q34203979-285685AE-3DC6-4752-9AA5-E6B36CAC5E62 Q34369456-AC053E5A-6552-46FC-97BE-EDD43D8D591C Q37092483-551A04FE-3AE0-41A4-A6A6-F95E4644B9B8 Q37196387-05ADB90B-B661-4AE1-8135-5A699C922FF5 Q37429908-D8F0EECF-88C3-491C-BF02-D27887D5D910 Q40451405-A7F2971A-1C98-4CFF-AF20-E5AEBF8D0087 Q42362331-2056299E-7165-401E-B213-5DCC3ECA1E9E Q42420987-11894447-6051-4D24-A3BA-32CF1E65FC79 Q43376098-901D0AC0-9BF5-4619-B070-55FF1CB8F110 Q47414868-7C57C48D-C04F-4FD0-B2FE-4103E4F15B1A Q47593121-A17348AF-D745-440A-BE44-A676787BDFD6 Q48092237-FAEB22A8-BE06-4815-9FBF-18688768FA1D Q48102344-F9FE6250-0CEE-4F5B-B068-28761E2686C3 Q48261931-E79C7A11-ECFE-42DB-9FC6-629DF845FBB9 Q48375491-1435F110-C117-4B45-AD82-753970AFD2D2 Q49150707-BC29A2DE-008F-4441-8E1D-7D920CBDCDA8 Q50237668-BD0440E2-7425-4593-90B1-3A9D94DA40B2 Q51416304-DD4A28A8-918D-41BC-ADF9-7BD18B87126E Q52148950-6FE515FC-D5D8-4FB2-9600-269AD26C1A5D Q52562075-4297684E-61F2-42E0-8639-3F73308F945B Q53189475-B1A2F53E-1E91-4984-8420-44CD3280A29A

P2860

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

http://www.wikidata.org/entity/Q35070122

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

@ast

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

@en

type

label

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

@ast

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

@en

prefLabel

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

@ast

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

@en

P1433

Q35070122-B5759234-0AFA-45FD-8BB1-D43A08376EB1

P1476

Q35070122-069527A8-76A1-4593-A73A-E67AAB1BA07F

P2093

Q35070122-2C1D99AB-698B-471D-A921-4E65ABA3E75C

Q35070122-3C1ECCD8-4335-4D7E-91EB-C33688594E61

Q35070122-41C7595C-E5E6-4868-B97E-C5BBA100BC0C

Q35070122-486877CB-C1F5-494A-B7A6-67DBD25C5667

Q35070122-92B0977D-8D14-4945-B600-D93E05EE906B

Q35070122-A1D317B0-97FC-4CFC-B5BD-0E1BEE531965

Q35070122-BA58205B-ED19-4BD3-A0A6-166B293BA58B

Q35070122-BFAFBD61-8C65-435B-977A-C98CFD261E3D

Q35070122-C7CFDC40-27A4-4122-8110-0893AB27BB33

Q35070122-FE05DEAA-106F-4489-89E8-8D886132732D

P2860

Q35070122-0241FC7A-3A3B-4772-B89F-84C548FBF5AB

Q35070122-0AA3E387-5A85-4708-9D66-6A0AA2841774

Q35070122-154BE52D-81ED-4B06-85E3-05DBD730BCB3

Q35070122-1C3B3ED1-5627-4CB0-83C6-61C4AA7CD633

Q35070122-1E0C3285-44A1-43E1-8B6E-576F5C8922B0

Q35070122-22D4920C-7778-4C16-AB07-5B622875D6A8

Q35070122-24559049-A246-4623-B0A4-1587082D3BF3

Q35070122-25CF7BA3-E339-416B-B4C3-5D7113866F03

Q35070122-2619530E-DFFF-4269-8E10-627585CE26B4

Q35070122-2EF94359-EEB4-49D9-A3FB-C4E5B9B8F9E0

P2888

Q35070122-B3B86209-0747-4A17-9112-E6C726089A16

P304

Q35070122-8F01F031-F013-4DD0-9E54-9132D8D76E54

P31

Q35070122-F8682887-55AC-487F-8AF9-81C2FB583F37

P356

Q35070122-E5EA9C53-0A19-494A-B5DA-B75E555305B4

P433

Q35070122-69529A2F-6AAD-44E1-8CB4-64E7239275D5

P478

Q35070122-B026B76A-B08A-4AE0-8C1C-F0834191F2CC

P577

Q35070122-8C90041F-DCC9-4493-9FC0-9E96C532E71A

P5875

Q35070122-944598CB-6A71-444C-A76A-A99779822A0F

P698

Q35070122-E38EE996-812C-4BFE-8962-10FB95814775

P921

Q35070122-221C4967-84B8-42BD-95EF-FC15F3FD1144

P932

Q35070122-49E217D6-49B5-4083-BA01-F389B7B6FC8B

P356

S00234-006-0122-Z

P1433

P1476

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

@en

P2093

Brian Haylock

http://www.w3.org/2001/XMLSchema#string

Carol Walker

http://www.w3.org/2001/XMLSchema#string

Daniel G du Plessis

http://www.w3.org/2001/XMLSchema#string

David J Husband

http://www.w3.org/2001/XMLSchema#string

Diane Fildes

http://www.w3.org/2001/XMLSchema#string

John Broome

http://www.w3.org/2001/XMLSchema#string

Kathy A Joyce

http://www.w3.org/2001/XMLSchema#string

Michael D Jenkinson

http://www.w3.org/2001/XMLSchema#string

Peter C Warnke

http://www.w3.org/2001/XMLSchema#string

Trevor S Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods for assessing agreement between two methods of clinical measurement

Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

The prognostic role of vessel productive changes and vessel density in oligodendroglioma.

Cerebral perfusion imaging using contrast-enhanced MRI.

Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component.

Advances in the biology and treatment of oligodendrogliomas.

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma".

Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.

Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors.

P2888

s00234-006-0122-z

P304

703-713

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00234-006-0122-Z

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6851761

http://www.w3.org/2001/XMLSchema#string

P698

16937145

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte

P932

1592467

http://www.w3.org/2001/XMLSchema#string